Rapamycin Restores Different Patterns of Cytokine Expression to Dexamethasone Treatment on CD14++CD16+ Monocytes from Steroid-Resistant Asthma Patients
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b22-00480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Hyun Seung Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Institute, Seoul National University Hospital. Hauptthemen laut MEDLINE: Cytokines, Asthma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Institute, Seoul National University Hospital.
- Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center.
- Department of Internal Medicine, Seoul National University Hospital.
- Department of Internal Medicine, Seoul National University College of Medicine.
- Department of Molecular Microbiology and Immunology, Brown University.
Zitieren
APA
Lee, H. S., Park, H. W., & Lee, S. Y. (2023). Rapamycin Restores Different Patterns of Cytokine Expression to Dexamethasone Treatment on CD14++CD16+ Monocytes from Steroid-Resistant Asthma Patients. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00480
Vancouver
Lee HS, Park HW, Lee SY. Rapamycin Restores Different Patterns of Cytokine Expression to Dexamethasone Treatment on CD14++CD16+ Monocytes from Steroid-Resistant Asthma Patients. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00480
BibTeX
@article{Lee2023,
author = {Lee, Hyun Seung and Park, Heung-Woo and Lee, Suh-Young},
title = {Rapamycin Restores Different Patterns of Cytokine Expression to Dexamethasone Treatment on CD14++CD16+ Monocytes from Steroid-Resistant Asthma Patients},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b22-00480}
}
EUVIMED